Renub

    Cardiac Bio Implant Devices Market, Size, Global Forecast 2023-2030, Industry Trends, Growth, Share, Outlook, Impact of Inflation, Opportunity Company Analysis

    Excel: 8 Hours
    PDF: 24 Hours
    Aug 2023
    Pages: 210

    Global Cardiac Bio-Implants Device Market Outlook

    Global Cardiac Bio-Implants Device Market size is estimated to be US$ 60.20 Billion by 2030, according to Renub Research. The most common cause of mortality worldwide is cardiovascular disease (CVD), which is characterized by constricted blood vessels that raise the risk of heart attacks and strokes. Blood flow restoration frequently involves surgical procedures, including coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI). 

    However, sufferers are nonetheless at danger for consequences which includes graft failure and in-stent restenosis (ISR) that may worsen their condition and boom mortality. Researchers are developing sophisticated cardiovascular bioimplants with sensors and actual-time tracking talents to address these issues. In order to prevent ISR and graft failure, those technologies are trying to find to discover ailment symptoms early, even before signs seem.

    cardiac-bio-implant-devices-market


    Worldwide cardiac bio-implants Market is predicted to show off a CAGR of 7.13% at some point of the period 2022–2030

    A large driving force of market expansion is the growing attractiveness of bio-implant treatments that are desired over alternatives like arthroscopy and physical therapy due to their better fulfillment prices and biocompatibility. The market will grow as a result of things consisting of the improved prevalence of orthopedic and cardiovascular illnesses, the old aged populace, converting existence, and the growing use of beauty surgical operation.

    According to data from the Centers for Disease Control and Prevention, coronary heart disorder, this influences over 20.1 million people elderly 20 and over, is the most commonplace form of coronary heart disease in the USA. An anticipated 805,000 heart attacks arise annually in the US, with one happening each 40 seconds. The growing incidence of chronic situations further will increase the demand for bioimplants. The global cardiac bio-implants market changed into worth USD 34.70 Billion in 2022.


    Rising target sickness occurrence, heart assault incidence, remedy investment, and healthcare spending are driving the cardiac resynchronization remedy marketplace growth

    The Cardiac Bio-Implant Device market is categorized into pacemakers, ICDs, and Cardiac Resynchronization Therapy (CRT). There are several motives why the CRT market is expanding. These consist of the high incidence of coronary coronary heart sickness, the upward push in heart failure and other cardiac problems, in addition to the growing range of aged people for the duration of the arena. The worldwide attractiveness of CRT is being driven by way of unhealthy existence and cardiovascular danger factors include diabetes, obesity, bad diets, state of no activity, and excessive alcohol use. These elements also make contributions to the improved incidence of heart disease. By 2050, a considerable part of the populace in the Asia-Pacific area is anticipated to be elderly, increasing the occurrence of cardiovascular sickness and the need for CRT.

    Increasing product releases are anticipated to drive market expansion throughout the projected period. For instance, in February 2021, Medtronic unveiled the TYRX absorbable Antibacterial envelope. This unique, single-use envelope has antibacterial qualities and is made to support cardiac implantable electronic devices or implanted neurostimulators.


    Rising number of people with cardiovascular disorders is predicted to propel the market for cardiac arrhythmias to considerable growth over the coming years, opening up attractive business prospects

    By Aррlісаtіоn, The Cardiac Bio-Implant Device market is segmented into Arrhythmias, Myocardial Ischemia, Acute Myocardial infarction, and Heart Failure. A number of variables, such as the rising global incidence of unhealthy lifestyle choices like smoking, binge drinking, and obesity, which increase a person's susceptibility to cardiac arrhythmias, are fueling the expansion of the arrhythmias sector. Additionally, increasing patient awareness helps the market grow. When the heart beats too slowly, too fast, or irregularly, arrhythmias happen.

    According to projections, 12.1 million Americans will have AFib by 2030. In 2019, 183,321 death certificates listed AFib as a contributing factor in 26,535 fatalities. Since AFib is associated with aging and women have greater life expectancies than men, it affects more women than men in Europe compared to African Americans. An important factor propelling the sector is the elevated death rate linked to arrhythmias. The industry is predicted to expand significantly over the next several years because of the rising number of individuals with cardiovascular disorders.


    With the growing inclination for less invasive treatments in the Cardiac Catheterization laboratory sector, fluoroscopy-guided catheter-based cardiology operations have increased dramatically over the past several decades

    By End User, The cardiac bio-implant device market is divided into Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization laboratories, and others. The growth of the Cardiac Catheterization laboratory market is primarily fueled by the increasing prevalence of cardiovascular disorders and advancements in Cardiac Catheterization lab technology. The rising incidence of cardiac diseases is expected to drive demand for Cardiac Catheterization lab services, which utilize various imaging techniques like angiography, echocardiography, and cardiac catheterization for diagnosis. For example, according to statistics from the British Heart Foundation, approximately 1,139,140 individuals were projected to be affected by heart and circulatory diseases in the UK in 2022, with 650,681 males and 488,320 females among them.

    Globally, the American Heart Association estimates that during 2020, 244.1 Million humans may be living with ischemic coronary heart disorder (IHD), with a higher occurrence among men (141.0 million) in comparison to women (103.1 million). The market is driven by means of factors consisting of good sized improvements in catheterization system, accelerated operator understanding, the emergence of progressive strategies, and the growing incidence of cardiac complications, necessitating the establishment of cardiac catheterization labs globally.


    Cardiac bio-implants market in the United States holds an enormous proportion and is projected to hold a regular growth trend at some stage in the upcoming years.

    By Countries, The cardiac bio-implant devices market is broken up into the US, Canada, France, Germany, Italy, Spain, the UK, Belgium, the Netherlands, Switzerland, China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, the Philippines, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, Turkey, the U.A.E., and Rest of World. The bio-implants market in the United States is driven by elements like the increasing prevalence of chronic illnesses and robust healthcare infrastructure, leading to huge growth. National health spending is projected to develop at a 5.4% annual rate, accomplishing USD 6.2 trillion by 2028. This rising healthcare expenditure creates possibilities for bio-implant improvement, whilst new product introductions like the T3 pro-tampered implant and Encode emergence healing Abutment through ZimVie further make contributions to market increase.


    Key Company

    F. Hoffman-La Roche, Eurofins Scientific, Illumina, Inc., Natera Inc., Abbott Laboratories, Thermo Fisher Scientific, Quest Diagnostics, and Agilent Technologies are the few companies working in the cardiac bio-implant device market.


    Renub Research latest report “Cardiac Bio Implant Devices Market, Global Forecast By Туре (Pacemaker, ICDs, Cardiac Resyncronization Therapy(CRT)), Аррlісаtіоn (Arrhythmias, Myocardial Ischemia, Acute Myocardial Infarction, Heart Failure), End-User (Hospitals, Ambulatory Surgical Centers', Cardiac Catheterization Laboratories, Others), Country ( United States, Canada, France, Germany, Italy, Spain, the United Kingdom, Belgium, Netherlands, Switzerland, China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, Philippines, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, Turkey, U.A.E., and ROW), Companies (F. Hoffman-La Roche, Eurofins Scientific, Illumina, Inc., Natera Inc., Abbott Laboratories, Thermo Fisher Scientific, Quest Diagnostics, and Agilent Technologies)” provides a detailed analysis of Cardiac Bio Implant Devices Industry.

    cardiac-bio-implant-devices-market-share

    Tуре – Market have been covered from 3 viewpoints:

    1.    Pacemaker
    2.    ICDs (Implantable Cardioverter Defibrillator)
    3.    CRT (Cardiac Resynchronization Therapy)


    Аррlісаtіоn – Market have been covered from 4 viewpoints:

    1.    Arrhythmias
    2.    Myocardial Ischemia
    3.    Acute Myocardial Infarction
    4.    Heart Failure


    End-User – Market have been covered from 4 viewpoints:

    1.    Hospitals
    2.    Cardiac Care Centers
    3.    Ambulatory Centers & Home Care
    4.    Academic Institutes
    5.    Others


    Country – Market have been covered from 27 viewpoints:

    1.    North America

    1.1    United States
    1.2    Canada

    2.    Europe

    2.1    France
    2.2    Germany
    2.3    Italy
    2.4    Spain
    2.5    United Kingdom
    2.6    Belgium
    2.7    Netherlands
    2.8    Switzerland
    2.9    Turkey

    3.    Asia Pacific

    3.1    China
    3.2    Japan
    3.3    India
    3.4    Australia
    3.5    South Korea
    3.6    Thailand
    3.7    Malaysia
    3.8    Indonesia
    3.9    Philippines

    4.    Latin America

    4.1    Brazil
    4.2    Mexico
    4.3    Argentina

    5.    Middle East & Africa

    5.1    Saudi Arabia
    5.2    U.A.E
    5.3    South Africa

    6.    Rest of World


    Company Insights:

    •    Overview
    •    Recent Development
    •    Revenue


    Companies Covered:

    1.    F. Hoffman-La Roche
    2.    Eurofins Scientific
    3.    Illumina, Inc.
    4.    Natera Inc.
    5.    Abbott Laboratories
    6.    Thermo Fisher Scientific
    7.    Quest Diagnostics
    8.    Agilent Technologies
     


    Report Details:

    Report Features Details
    Base Year 2022
    Historical Period 2018 - 2022
    Forecast Period 2023 - 2030
    Market US$ Billion
    Segment Covered Туре, Аррlісаtіоn, End-User, and Countries
    Countries Covered United States, Canada, France, Germany, Italy, Spain, United Kingdom, Belgium, Netherlands, Switzerland, Turkey, China, Japan, India, Australia, South Korea, Thailand, Malaysia, Indonesia, Philippines, Brazil, Mexico, Argentina, Saudi Arabia, U.A.E, South Africa, and Rest of World
    Companies Covered F. Hoffman-La Roche, Eurofins Scientific, Illumina, Inc., Natera Inc., Abbott Laboratories, Thermo Fisher Scientific, Quest Diagnostics, and Agilent Technologies
    Customization Scope 20% Free Customization
    Post-Sale Analyst Support 1 Year (52 Weeks)
    Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on request)

    1.    Introduction

    2.    Research Methodology

    3.    Executive Summary

    4.    Market Dynamics

    4.1    Growth Drivers
    4.2    Challenges


    5.    Cardiac Bio Implant Devices Market

    6.    Market Share – Cardiac Bio Implant Devices Market

    6.1    By Туре
    6.2    By Аррlісаtіоn
    6.3    By End User
    6.4    By Countries


    7.    Туре – Cardiac Bio Implant Devices Market

    7.1    Pacemaker
    7.2    ICDs (Implantable Cardioverter Defibrillator)
    7.3    CRT (Cardiac Resynchronization Therapy)


    8.    Аррlісаtіоn – Cardiac Bio Implant Devices Market

    8.1    Arrhythmias
    8.2    Myocardial Ischemia
    8.3    Acute Myocardial Infarction
    8.4    Heart Failure


    9.    End-User – Cardiac Bio Implant Devices Market

    9.1    Hospitals
    9.2    Ambulatory Surgical Centers
    9.3    Cardiac Catheterization Laboratories
    9.4    Others


    10.    Countries - Cardiac Bio Implant Devices Market

    10.1    North America

    10.1.1    United States
    10.1.2    Canada

    10.2    Europe

    10.2.1    France
    10.2.2    Germany
    10.2.3    Italy
    10.2.4    Spain
    10.2.5    United Kingdom
    10.2.6    Belgium
    10.2.7    Netherlands
    10.2.8    Switzerland
    10.2.9    Turkey

    10.3    Asia Pacific

    10.3.1    China
    10.3.2    Japan
    10.3.3    India
    10.3.4    Australia
    10.3.5    South Korea
    10.3.6    Thailand
    10.3.7    Malaysia
    10.3.8    Indonesia
    10.3.9    Philippines

    10.4    Latin America

    10.4.1    Brazil
    10.4.2    Mexico
    10.4.3    Argentina

    10.5    Middle East & Africa

    10.5.1    Saudi Arabia
    10.5.2    U.A.E
    10.5.3    South Africa

    10.6    Rest of World


    11.    Porter Five Forces Analysis - Cardiac Bio Implant Devices Market

    11.1    Bargaining Power of Buyers
    11.2    Bargaining Power of Suppliers
    11.3    Degree of Rivalry
    11.4    Threat of New Entrants
    11.5    Threat of Substitutes


    12.    SWOT Analysis - Cardiac Bio Implant Devices Market

    12.1    Strength
    12.2    Weakness
    12.3    Opportunity
    12.4    Threat


    13.    Key Players Analysis

    13.1    F. Hoffman-La Roche

    13.1.1    Overview
    13.1.2    Recent Development 
    13.1.3    SWOT Analysis
    13.1.4    Revenue

    13.2    Eurofins Scientific

    13.2.1    Overview
    13.2.2    Recent Development 
    13.2.3    SWOT Analysis
    13.2.4    Revenue

    13.3    Illumina, Inc.

    13.3.1    Overview
    13.3.2    Recent Development
    13.3.3    SWOT Analysis
    13.3.4    Revenue

    13.4    Natera Inc.

    13.4.1    Overview
    13.4.2    Recent Development
    13.4.3    SWOT Analysis
    13.4.4    Revenue

    13.5    Abbott Laboratories

    13.5.1    Overview
    13.5.2    Recent Development
    13.5.3    SWOT Analysis
    13.5.4    Revenue

    13.6    Thermo Fisher Scientific

    13.6.1    Overview
    13.6.2    Recent Development 
    13.6.3    SWOT Analysis
    13.6.4    Revenue

    13.7    Quest Diagnostics

    13.7.1    Overview
    13.7.2    Recent Development
    13.7.3    SWOT Analysis
    13.7.4    Revenue

    13.8    Agilent Technologies

    13.8.1    Overview
    13.8.2    Recent Development
    13.8.3    SWOT Analysis
    13.8.4    Revenue


    List of Figures:

    Figure-01:    Global – Cardiac Bio Implant Devices Market (Billion US$), 2018 – 2022
    Figure-02:    Global – Forecast for Cardiac Bio Implant Devices Market (Billion US$), 2023 – 2030
    Figure-03:    Туре – Pacemaker Market (Billion US$), 2018 – 2022
    Figure-04:    Туре – Forecast for Pacemaker Market (Billion US$), 2023 – 2030
    Figure-05:    Туре – ICDs (Implantable Cardioverter Defibrillator) Market (Billion US$), 2018 – 2022
    Figure-06:    Туре – Forecast for ICDs (Implantable Cardioverter Defibrillator) Market (Billion US$), 2023 – 2030
    Figure-07:    Туре – CRT (Cardiac Resynchronization Therapy) Market (Billion US$), 2018 – 2022
    Figure-08:    Туре – Forecast for CRT (Cardiac Resynchronization Therapy) Market (Billion US$), 2023 – 2030
    Figure-09:    Аррlісаtіоn – Arrhythmias Market (Billion US$), 2018 – 2022
    Figure-10:    Аррlісаtіоn – Forecast for Arrhythmias Market (Billion US$), 2023 – 2030
    Figure-11:    Аррlісаtіоn – Myocardial Ischemia Market (Billion US$), 2018 – 2022
    Figure-12:    Аррlісаtіоn – Forecast for Myocardial Ischemia Market (Billion US$), 2023 – 2030
    Figure-13:    Аррlісаtіоn – Acute Myocardial Infarction Market (Billion US$), 2018 – 2022
    Figure-14:    Аррlісаtіоn – Forecast for Acute Myocardial Infarction Market (Billion US$), 2023 – 2030
    Figure-15:    Аррlісаtіоn – Heart Failure Market (Billion US$), 2018 – 2022
    Figure-16:    Аррlісаtіоn – Forecast for Heart Failure Market (Billion US$), 2023 – 2030
    Figure-17:    End-User – Hospitals Market (Billion US$), 2018 – 2022
    Figure-18:    End-User – Forecast for Hospitals Market (Billion US$), 2023 – 2030
    Figure-19:    End-User – Ambulatory Surgical Centers Market (Billion US$), 2018 – 2022
    Figure-20:    End-User – Forecast for Ambulatory Surgical Centers Market (Billion US$), 2023 – 2030
    Figure-21:    End-User – Cardiac Catheterization Laboratories Market (Billion US$), 2018 – 2022
    Figure-22:    End-User – Forecast for Cardiac Catheterization Laboratories Market (Billion US$), 2023 – 2030
    Figure-23:    End-User – Others Market (Billion US$), 2018 – 2022
    Figure-24:    End-User – Forecast for Others Market (Billion US$), 2023 – 2030
    Figure-25:    United States – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-26:    United States – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-27:    Canada – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-28:    Canada – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-29:    France – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-30:    France – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-31:    Germany – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-32:    Germany – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-33:    Italy – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-34:    Italy – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-35:    Spain – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-36:    Spain – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-37:    United Kingdom – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-38:    United Kingdom – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-39:    Belgium – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-40:    Belgium – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-41:    Netherlands – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-42:    Netherlands – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-43:    Switzerland – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-44:    Switzerland – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-45:    Turkey – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-46:    Turkey – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-47:    China – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-48:    China – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-49:    Japan – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-50:    Japan – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-51:    India – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-52:    India – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-53:    Australia – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-54:    Australia – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-55:    South Korea – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-56:    South Korea – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-57:    Thailand – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-58:    Thailand – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-59:    Malaysia – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-60:    Malaysia – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-61:    Indonesia – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-62:    Indonesia – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-63:    Philippines – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-64:    Philippines – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-65:    Brazil – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-66:    Brazil – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-67:    Mexico – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-68:    Mexico – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-69:    Argentina – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-70:    Argentina – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-71:    Saudi Arabia – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-72:    Saudi Arabia – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-73:    United Arab Emirates (UAE) – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-74:    United Arab Emirates (UAE) – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-75:    South Africa – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-76:    South Africa – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-77:    Rest of the World – Cardiac Bio Implant Devices Market (Million US$), 2018 – 2022
    Figure-78:    Rest of the World – Forecast for Cardiac Bio Implant Devices Market (Million US$), 2023 – 2030
    Figure-79:    F. Hoffman-La Roche – Global Revenue (Billion US$), 2018 – 2022
    Figure-80:    F. Hoffman-La Roche – Forecast for Global Revenue (Billion US$), 2023 – 2030
    Figure-81:    Eurofins Scientific – Global Revenue (Billion US$), 2018 – 2022
    Figure-82:    Eurofins Scientific – Forecast for Global Revenue (Billion US$), 2023 – 2030
    Figure-83:    Illumina, Inc. – Global Revenue (Billion US$), 2018 – 2022
    Figure-84:    Illumina, Inc. – Forecast for Global Revenue (Billion US$), 2023 – 2030
    Figure-85:    Natera Inc. – Global Revenue (Million US$), 2018 – 2022
    Figure-86:    Natera Inc. – Forecast for Global Revenue (Million US$), 2023 – 2030
    Figure-87:    Abbott Laboratories – Global Revenue (Billion US$), 2018 – 2022
    Figure-88:    Abbott Laboratories – Forecast for Global Revenue (Billion US$), 2023 – 2030
    Figure-89:    Thermo Fisher Scientific – Global Revenue (Billion US$), 2018 – 2022
    Figure-90:    Thermo Fisher Scientific – Forecast for Global Revenue (Billion US$), 2023 – 2030
    Figure-91:    Quest Diagnostics – Global Revenue (Billion US$), 2018 – 2022
    Figure-92:    Quest Diagnostics – Forecast for Global Revenue (Billion US$), 2023 – 2030
    Figure-93:    Agilent Technologies – Global Revenue (Billion US$), 2018 – 2022
    Figure-94:    Agilent Technologies – Forecast for Global Revenue (Billion US$), 2023 – 2030


    List of Tables:

    Table-01:    Global – Cardiac Bio Implant Devices Market Share by Туре (Percent), 2018 – 2022
    Table-02:    Global – Forecast for Cardiac Bio Implant Devices Market Share by Туре (Percent), 2023 – 2030
    Table-03:    Global – Cardiac Bio Implant Devices Market Share by Application (Percent), 2018 – 2022
    Table-04:    Global – Forecast for Cardiac Bio Implant Devices Market Share by Application (Percent), 2023 – 2030
    Table-05:    Global – Cardiac Bio Implant Devices Market Share by End-User (Percent), 2018 – 2022
    Table-06:    Global – Forecast for Cardiac Bio Implant Devices Market Share by End-User (Percent), 2023 – 2030
    Table-07:    Global – Cardiac Bio Implant Devices Market Share by Countries (Percent), 2018 – 2022
    Table-08:    Global – Forecast for Cardiac Bio Implant Devices Market Share by Countries (Percent), 2023 – 2030

    • Description
      Price
    • Chapter 1, 4 & 5     Pages : 7
      $300
    • Chapter 7     Pages : 6
      $300
    • Chapter 8     Pages : 8
      $300
    • Chapter 9     Pages : 8
      $300
    • Chapter 10.1     Pages : 4
      $200
    • Chapter 10.2     Pages : 18
      $500
    • Chapter 10.3     Pages : 18
      $500
    • Chapter 10.4     Pages : 6
      $200
    • Chapter 10.5 & 10.6     Pages : 8
      $200
    • Chapter 11     Pages : 5
      $200
    • Chapter 12     Pages : 4
      $200
    • Chapter 13.1     Pages : 6
      $150
    • Chapter 13.2     Pages : 6
      $150
    • Chapter 13.3     Pages : 6
      $150
    • Chapter 13.4     Pages : 6
      $150
    • Chapter 13.5     Pages : 6
      $150
    • Chapter 13.6     Pages : 6
      $150
    • Chapter 13.7     Pages : 6
      $150
    • Chapter 13.8     Pages : 6
      $150

    Related Reports